Victor M Karpyak MD Ph.D
Addiction
Consultant, Department of Psychiatry and Psychology Professor of Psychiatry, Mayo Clinic College of Medicine
Join to View Full Profile
200 1st St SWRochester, MN 55905
Phone+1 507-284-2511
Dr. Karpyak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Addiction Psychiatry, 2005 - 2006- Mayo Clinic College of Medicine and Science (Rochester)Residency, Psychiatry, 2000 - 2003
Odessa Medical UniversityClass of 1980
Certifications & Licensure
MN State Medical License 2000 - 2026
American Board of Psychiatry and Neurology Psychiatry- American Board of Psychiatry and Neurology Addiction Psychiatry
Publications & Presentations
PubMed
- Buprenorphine's Effect on the Human Immune System and Inflammation.Samuel D Shin, Rachel Branning, Michele McGinnis, Alexandra Shin, Ming-Fen Ho
Clinical and Translational Science. 2025-03-01 - IL17RB genetic variants are associated with acamprosate treatment response in patients with alcohol use disorder: A proteomics-informed genomics study.Ming-Fen Ho, Cheng Zhang, James S Cohan, Mustafa Tuncturk, Robin M Heider
Brain, Behavior, and Immunity. 2024-08-01 - 1 citationsTherapeutic Content of Mobile Phone Applications for Substance Use Disorders: An Umbrella Review.Tyler S Oesterle, Daniel K Hall-Flavin, Nicholas L Bormann, Larissa L Loukianova, David C Fipps
Mayo Clinic Proceedings. Digital Health. 2024-06-01
Journal Articles
- Genetic markers associated with abstinence length in alcohol-dependent subjects treated with acamprosate.Karpyak VM, Biernacka JM, Geske JR, Jenkins GD, Cunningham JM, Rüegg J, Kononenko O, Leontovich AA, Abulseoud OA, Hall-Flavin DK, Loukianova LL, Schneekloth TD, Skime ..., Transl Psychiatry, 10/7/2014
Press Mentions
Can Hormones Guide Sex-Specific Treatments for Alcohol Use Disorder?September 30th, 2024
Major Mayo/Hazelden Study May Advance Personalized Medicine for Alcohol Use DisorderSeptember 9th, 2019
Mayo Clinic Minute: How Genetics Factor into Treating Alcohol Use DisorderDecember 26th, 2018- Join now to see all
Grant Support
- Integrated Therapies for Alcohol use in Alcohol-associated Liver Disease (ITAALD) – Mayo ClinicMAYO CLINIC ROCHESTER2018–2029
- Genomics of Alcohol Withdrawal and Treatment Response to BenzodiazepinesMAYO CLINIC ROCHESTER2023–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
